No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Protagenic Therapeutics Shares Are Trading Higher After the Company Announced It Filed for an Offering of 5.84 Million Shares of Common Stock.
Express News | Protagenic Therapeutics Inc - on Nov 19, Co Receives Nasdaq Delist Determination Letter
10-Q: Q3 2024 Earnings Report
Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
10-Q: Q2 2024 Earnings Report
No Data